# Assisted evaluation of aniline's in silico toxicity using artificial intelligence and its simultaneous determination as a toxic impurity with widely used cardiovascular drugs using a green micellar chromatographic method

**Authors:** Alaa Ahmed Mostafa, Soad S. Abd El-Hay, Youstina Mekhail Metias, Mohamed Adel Said, Michael Gamal Fawzy

PMC · DOI: 10.1039/d5ra09502f · RSC Advances · 2026-02-18

## TL;DR

A new eco-friendly method uses AI and green chemistry to detect toxic aniline and salicylic acid impurities in cardiovascular drugs.

## Contribution

First AI-based molecular docking study of aniline toxicity combined with a green micellar HPLC method for simultaneous impurity detection.

## Key findings

- AI docking simulations identified cytochrome P450 binding sites linked to aniline-induced methemoglobinemia.
- A green micellar HPLC method accurately quantified aniline and salicylic acid alongside four cardiovascular drugs.
- The method met ICH guidelines with high accuracy and greenness scores of 0.80 and 0.85.

## Abstract

The safety of pharmaceutical products is critically influenced by the presence of impurities and degradation products. Aniline (ANN) is a very toxic degradation product of atorvastatin (ATN), which can cause life-threatening diseases such as methemoglobinemia. For the first time, a comprehensive artificial intelligence study using molecular docking was applied to assess the ANN-induced methemoglobinemia by simulating different binding energies in different pockets of cytochrome P450 (CYP 1A2), revealing the most suitable position leading to toxicity. Moreover, environmental concerns have become increasingly important due to the toxic effects of the excessive use of organic solvents in chromatographic separation systems. Accordingly, greener surfactant systems comprising sodium dodecyl sulfate (SDS) and polyoxyethylene-23-lauryl ether (Brij-35) were employed as safer alternatives were used for the quantitation of ANN in the presence of salicylic acid as an aspirin impurity alongside four widely used cardiovascular drugs of aspirin (APN), atenolol (AEN), atorvastatin calcium (ATN), and losartan potassium (LSN) in pure form and pharmaceuticals. The method validation was done according to the International Conference for Harmonisation (ICH) guidelines with linearity ranges of (10–200), (5–140), (5–100), (5–130), (0.5–40), and (0.5–30) µg mL−1 for APN, AEN, ATN, LSN, SAA, and ANN, respectively, and the results obtained were highly accurate. The greenness of the proposed method was ascertained using the green analytical procedure index: score (0.80), blue applicability grade index: score (0.85), and the Analytical GREEnness calculator. A statistical comparison between the results of our study and the reported method showed no significant difference in precision or accuracy.

An eco-friendly micellar HPLC method, integrated with an AI-assisted docking approach, enables the simultaneous determination of aniline and salicylic acid impurities with four cardiovascular drugs, to predict aniline toxicity.

## Linked entities

- **Proteins:** CYP71B9 (cytochrome P450, family 71, subfamily B, polypeptide 9), CYP1A2 (cytochrome P450 family 1 subfamily A member 2)
- **Chemicals:** aniline (PubChem CID 6115), atorvastatin (PubChem CID 60823), salicylic acid (PubChem CID 338), sodium dodecyl sulfate (PubChem CID 3423265), aspirin (PubChem CID 2244), atenolol (PubChem CID 2249), atorvastatin calcium (PubChem CID 60822), losartan potassium (PubChem CID 11476710)
- **Diseases:** methemoglobinemia (MONDO:0001117)

## Full-text entities

- **Genes:** SAA [NCBI Gene 6287], LDLR (low density lipoprotein receptor) [NCBI Gene 3949] {aka LDLCQ2}, TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}, ANPEP (alanyl aminopeptidase, membrane) [NCBI Gene 290] {aka AP-M, AP-N, APN, CD13, GP150, LAP1}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, PPIG (peptidylprolyl isomerase G) [NCBI Gene 9360] {aka CARS-Cyp, CYP, SCAF10, SRCyp}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, SPN (sialophorin) [NCBI Gene 6693] {aka CD43, GALGP, GPL115, LEU-22, LSN}, CYP2C19 (cytochrome P450 family 2 subfamily C member 19) [NCBI Gene 1557] {aka CPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19}, CYP1A2 (cytochrome P450 family 1 subfamily A member 2) [NCBI Gene 1544] {aka CP12, CYPIA2, P3-450, P450(PA)}
- **Diseases:** hypoxic injury (MESH:D002534), non-communicable diseases (MESH:D000073296), heart disease (MESH:D006331), stroke (MESH:D020521), DILI (MESH:D056486), Hypertriglyceridemia (MESH:D015228), inflammatory (MESH:D007249), deaths (MESH:D003643), respiratory toxicity (MESH:D012140), methemoglobinemia (MESH:D008708), carcinogenic (MESH:D011230), hypertension (MESH:D006973), pain (MESH:D010146), diabetes (MESH:D003920), Cardiovascular diseases (MESH:D002318), toxicities (MESH:D064420)
- **Chemicals:** Val (MESH:D014633), BP (MESH:C038809), water (MESH:D014867), Tyr (MESH:D014443), APN (MESH:D001241), Leu (MESH:D007930), iron (MESH:D007501), hydrogen (MESH:D006859), alcohol (MESH:D000438), butanol (MESH:D000440), SDS (MESH:D012967), ANN (MESH:C023650), Gly (MESH:D005998), NaOH (MESH:D012972), cholesterol (MESH:D002784), BN (MESH:C072598), methanol (MESH:D000432), mevalonate (MESH:D008798), 1B (-), Sodium dihydrogen phosphate (MESH:C018279), 1-butanol (MESH:D020001), Salicylic acid (MESH:D020156), sodium (MESH:D012964), potassium (MESH:D011188), polyoxyethylene-(23)-dodecyl ether (MESH:C552190), phosphate (MESH:D010710), ATN (MESH:D000069059), potassium dihydrogen phosphate (MESH:C013216), amino acids (MESH:D000596), AEN (MESH:D001262), Ile (MESH:D007532), prostaglandins (MESH:D011453), phosphoric acid (MESH:C030242), LSN (MESH:D019808), Asp (MESH:D001224), Phe (MESH:D010649), Brij-35 (MESH:C515901), triglycerides (MESH:D014280), acetonitrile (MESH:C032159)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G1314A, (S) of -4, G1311A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915648/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915648/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915648/full.md

---
Source: https://tomesphere.com/paper/PMC12915648